We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Pharmacy (P), prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
Using a registered lasting power of attorney (LPA) - attorney duties, starting to act, gifting, ending, revoking an attorney.
You can make decisions on someone’s behalf if they appoint you using a…
As a property and financial affairs attorney, you make (or help the donor…
As a health and welfare attorney, you make (or help the donor make)…
You must register the lasting power of attorney (LPA) before you can start…
Any company or organisation you deal with on behalf of the donor can ask…
Keep a record of: important decisions you make and when you make them, for…
You must tell the Office of the Public Guardian (OPG) if: you or the donor…
A lasting power of attorney (LPA) can end in several ways. Usually it ends…
Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Guidance for Applicants wishing to apply for a Promising Innovative Medicines designation, pre-submission meeting or an EAMS Scientific Opinion.
Summary of the latest safety advice for medicines and medical device users
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).